肿瘤沉积联合淋巴结转移数目提高III期结肠癌预后准确性:CALGB/SWOG 80702 III期研究事后分析
该事后分析纳入CALGB/SWOG 80702 III期试验中2028例III期淋巴结阳性结肠癌患者,评估肿瘤沉积(TD)存在及数目对无病生存(DFS)和总生存(OS)的预后价值。结果显示TD阳性与更差的DFS(aHR=1.63,95%CI 1.33-1.98)和OS(aHR=1.59,95%CI 1.24-2.04)相关,且TD数目呈线性负性影响。联合TD数目与淋巴结转移数目可将部分pN1患者重新分期为pN2,其预后与初始pN2患者相似,提示可提高TNM分期预后准确性。
要点
- TD阳性与III期结肠癌更差的DFS和OS独立相关。
- TD数目对DFS和OS呈线性负性影响。
- 联合TD与淋巴结转移数目可重新分期部分pN1为pN2。
核心结论
- 联合肿瘤沉积数目与淋巴结转移数目可提高III期结肠癌TNM分期的预后准确性。
研究设计与样本
- CALGB/SWOG 80702 III期试验的事后分析,纳入2028例III期淋巴结阳性结肠癌患者。
主要发现
- 2028例中TD阳性524例(26%),TD阴性1504例(74%)。
- TD阳性患者中80例(15.4%)为pN1c,239例(46.1%)为pN1a/b,200例(38.5%)为pN2。
- TD存在与更差DFS(aHR=1.63,95%CI 1.33-1.98)和OS(aHR=1.59,95%CI 1.24-2.04)相关。
- TD的负性影响在pN1a/b和pN2组均可见,且TD数目对DFS和OS呈线性负性影响。
- 联合TD与淋巴结转移数目后,1470例pN1中104例(7.1%)重新分期为pN2,其3年DFS率65.4% vs 80.5%(P=0.0003),5年OS率87.9% vs 69.1%(P<0.0001)。
临床怎么用
- 在III期淋巴结阳性结肠癌中,应关注TD的存在及数目以辅助预后评估。
- 可考虑将TD数目与淋巴结转移数目联合用于TNM分期细化。
局限性
- 为事后分析,结果需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In colon cancer, tumor deposits (TD) are considered in assigning prognosis and staging only in the absence of lymph node metastasis (i.e. stage III pN1c tumors). We aimed to evaluate the prognostic value of the presence and the number of TD in patients with stage III, node-positive colon cancer. PATIENTS AND METHODS: All participants from the CALGB/SWOG 80702 phase III trial were included in this post hoc analysis. Pathology reports were reviewed for the presence and the number of TD, lymphovascular and perineural invasion. Associations with disease-free survival (DFS) and overall survival (OS) were evaluated by multivariable Cox models adjusting for sex, treatment arm, T-stage, N-stage, lymphovascular invasion, perineural invasion and lymph node ratio. RESULTS: Overall, 2028 patients were included with 524 (26%) TD-positive and 1504 (74%) TD-negative tumors. Of the TD-positive patients, 80 (15.4%) were node negative (i.e. pN1c), 239 (46.1%) were pN1a/b (<4 positive lymph nodes) and 200 (38.5%) were pN2 (≥4 positive lymph nodes). The presence of TD was associated with poorer DFS [adjusted hazard ratio (aHR) = 1.63, 95% CI 1.33-1.98] and OS (aHR = 1.59, 95% CI 1.24-2.04). The negative effect of TD was observed for both pN1a/b and pN2 groups. Among TD-positive patients, the number of TD had a linear negative effect on DFS and OS. Combining TD and the number of lymph node metastases, 104 of 1470 (7.1%) pN1 patients were re-staged as pN2, with worse outcomes than patients confirmed as pN1 (3-year DFS rate: 65.4% versus 80.5%, P = 0.0003; 5-year OS rate: 87.9% versus 69.1%, P = <0.0001). DFS was not different between patients re-staged as pN2 and those initially staged as pN2 (3-year DFS rate: 65.4% versus 62.3%, P = 0.4895). CONCLUSION: Combining the number of TD and the number of lymph node metastases improved the prognostication accuracy of tumor-node-metastasis (TNM) staging.
引用
- Cohen R, Shi Q, Meyers J, et al. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆. Ann Oncol. 2021. PMID: 34293461. doi:10.1016/j.annonc.2021.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。